Breast cancer is characterized by abnormal discontinuities in the lining cells of a woman’s milk duct. Large numbers of women die from breast cancer as a result of developing symptoms in the milk ducts. If the diagnosis is made early, the death rates can be decreased. For radiologists and physicians, manually analyzing mammography images for breast cancer become time-consuming. To prevent manual analysis and simplify the work of classification, this paper introduces a novel hybrid DenseNet121-based Extreme Learning Machine Model (ELM) for classifying breast cancer from mammogram images. The mammogram images were processed through preprocessing and data augmentation phase. The features were collected separately after the pooling and flatten layer at the first stage of the classification. Further, the features are fed as input to the proposed DenseNet121-ELM model’s fully connected layer as input. An extreme learning machine model has replaced the fully connected layer. The weights of the extreme learning machine have been updated by the AdaGrad optimization algorithm to increase the model’s robustness and performance. Due to its faster convergence speed than other optimization techniques, the AdaGrad algorithm optimization was chosen. In this research, the Digital Database for Screening Mammography (DDSM) dataset mammogram images were utilized, and the results are presented. We have considered the batch size of 32, 64, and 128 for the performance measure, accuracy, sensitivity, specificity, and computational time. The proposed DenseNet121+ELM model achieves 99.47% and 99.14% as training accuracy and testing accuracy for batch size 128. Also, it achieves specificity, sensitivity, and computational time of 99.37%, 99.94%, and 159.7731 minutes, respectively. Further, the comparison result of performance measures is presented for batch sizes 32, 64, and 128 to show the robustness of the proposed DenseNet121+ELM model. The automatic classification performance of the DenseNet121+ELM model has much potential to be applied to the clinical diagnosis of breast cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.